Italy
· Delayed Price · Currency is EUR Exact Sciences Statistics
Total Valuation
Exact Sciences has a market cap or net worth of EUR 9.06 billion. The enterprise value is 10.64 billion.
| Market Cap | 9.06B |
| Enterprise Value | 10.64B |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 188.64M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.33% |
| Shares Change (QoQ) | +0.81% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 186.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 86.15 |
| PS Ratio | 3.46 |
| PB Ratio | 4.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 138.00, with an EV/FCF ratio of 59.21.
| EV / Earnings | -11.27 |
| EV / Sales | 4.18 |
| EV / EBITDA | 138.00 |
| EV / EBIT | n/a |
| EV / FCF | 59.21 |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 1.06.
| Current Ratio | 2.73 |
| Quick Ratio | 2.12 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 32.14 |
| Debt / FCF | 13.08 |
| Interest Coverage | -6.09 |
Financial Efficiency
Return on equity (ROE) is -36.89% and return on invested capital (ROIC) is -2.08%.
| Return on Equity (ROE) | -36.89% |
| Return on Assets (ROA) | -1.83% |
| Return on Invested Capital (ROIC) | -2.08% |
| Return on Capital Employed (ROCE) | -3.40% |
| Revenue Per Employee | 376,487 |
| Profits Per Employee | -135,764 |
| Employee Count | 7,000 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 5.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.85 |
Income Statement
In the last 12 months, Exact Sciences had revenue of EUR 2.62 billion and -943.56 million in losses. Loss per share was -5.10.
| Revenue | 2.62B |
| Gross Profit | 1.83B |
| Operating Income | -163.65M |
| Pretax Income | -951.78M |
| Net Income | -943.56M |
| EBITDA | 35.24M |
| EBIT | -163.65M |
| Loss Per Share | -5.10 |
Balance Sheet
The company has 727.37 million in cash and 2.35 billion in debt, giving a net cash position of -1.62 billion.
| Cash & Cash Equivalents | 727.37M |
| Total Debt | 2.35B |
| Net Cash | -1.62B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.22B |
| Book Value Per Share | 11.76 |
| Working Capital | 802.96M |
Cash Flow
In the last 12 months, operating cash flow was 299.45 million and capital expenditures -119.83 million, giving a free cash flow of 179.62 million.
| Operating Cash Flow | 299.45M |
| Capital Expenditures | -119.83M |
| Free Cash Flow | 179.62M |
| FCF Per Share | n/a |
Margins
Gross margin is 69.76%, with operating and profit margins of -6.25% and -36.06%.
| Gross Margin | 69.76% |
| Operating Margin | -6.25% |
| Pretax Margin | -36.37% |
| Profit Margin | -36.06% |
| EBITDA Margin | 1.35% |
| EBIT Margin | -6.25% |
| FCF Margin | 6.86% |
Dividends & Yields
Exact Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.33% |
| Shareholder Yield | -2.33% |
| Earnings Yield | -10.42% |
| FCF Yield | 1.98% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Exact Sciences has an Altman Z-Score of 1.33. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | n/a |